Stimcell Energetics (STME) EPS (Basic) Growth (1y) (2017 - 2024)
Stimcell Energetics (STME) EPS (Basic) Growth (1y) (2017 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -18.87% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 13.56% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 18.90% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 97.93% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 92.23% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 114.97% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -29.95% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2024 | 38.48% |
| Feb 29, 2024 | 83.71% |
| Nov 30, 2023 | 57.60% |
| Aug 31, 2023 | 50.25% |
| May 31, 2023 | 51.26% |
| Feb 28, 2023 | 1.11% |
| Nov 30, 2022 | 18.85% |
| Aug 31, 2022 | 35.88% |
| May 31, 2022 | 18.93% |
| Feb 28, 2022 | 37.00% |
| Nov 30, 2021 | 12.28% |
| Aug 31, 2021 | -8.11% |
| May 31, 2021 | 32.20% |
| Feb 28, 2021 | 53.41% |
| Nov 30, 2020 | 42.14% |
| Aug 31, 2020 | 31.69% |
| May 31, 2020 | 82.53% |
| Feb 29, 2020 | -276.72% |
| Nov 30, 2019 | -299.65% |
| Aug 31, 2019 | -196.28% |